Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study
Creemers, Sara G, Feelders, Richard A, de Jong, Frank H, Franssen, Gaston J H, de Rijke, Yolanda B, van Koetsveld, Peter M, Hofland, Leo JVolume:
104
Langue:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jc.2019-00217
Date:
August, 2019
Fichier:
PDF, 1.30 MB
english, 2019